PTH and cranioectodermal dysplasia: Our studies have demonstrated a profound deficiency of vitamin D in children with CeD in the active phase of the disease (14.8 ± 1.04 ng/ml), in parallel with increased levels of parathyroid hormone and alkaline phosphatase, and reduced concentrations of calcium and phosphorus in the blood serum.